98 results on '"Cao, Davide"'
Search Results
2. The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent
3. Depression and ischemic heart disease
4. Impact of Bleeding Risk and Inflammation on Cardiovascular Outcomes After Percutaneous Coronary Intervention.
5. Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review.
6. Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention.
7. 1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI.
8. Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention.
9. P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.
10. Provisional Strategy for Left Main Stem Bifurcation Disease: A State-of-the-Art Review of Technique and Outcomes.
11. Predictors of antiplatelet cessation in a real-world patient population undergoing non-cardiac surgery after PCI
12. Clopidogrel Monotherapy After 1-Month DAPT in Diabetic Patients Undergoing PCI: Is Less Always More?
13. Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index.
14. Recent Advances in Antiplatelet Therapy in Complex Percutaneous Coronary Intervention.
15. Reply: Decoding Ticagrelor Dyspnea: Central Apnea Screening Before Drug Discontinuation.
16. Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy.
17. Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.
18. Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI.
19. 3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation.
20. Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI.
21. Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG.
22. Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent.
23. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.
24. TCT-728 Impact of Neutrophil-to-Lymphocyte Ratio on Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
25. Ticagrelor Monotherapy After Coronary Stenting: Is the GLASS Half Full or Half Empty?
26. Stick to the guidelines or clinical judgment: A toss up?
27. TCT-38 Ticagrelor With and Without Aspirin in Patients With Previous Coronary Artery Bypass Graft Undergoing Percutaneous Coronary Intervention: The TWILIGHT-CABG Subanalysis.
28. Sodium bicarbonate, contrast-associated acute kidney injury, and long-term outcomes: The end of an era?
29. TCT-158 Pooled Analysis of Patients Undergoing Complex PCI With the Dual-Therapy COMBO Stent: The MEGA-COMBO Complex-PCI Analysis.
30. TCT-13 Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI.
31. Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality.
32. PREDICTORS OF ANTIPLATELET CESSATION IN A REAL-WORLD PATIENT POPULATION WITH CORONARY STENTS UNDERGOING NONCARDIAC SURGERY.
33. IMPACT OF CHRONIC THROMBOCYTOPENIA ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL.
34. TCT-39 Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index: TWILIGHT-BMI Analysis.
35. PROGNOSTIC VALUE OF ELEVATED C-REACTIVE PROTEIN AMONG DIABETIC PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.
36. SAFETY AND EFFICACY OF 1-MONTH VERSUS 3-MONTH DUAL ANTIPLATELET THERAPY IN HIGH BLEEDING RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS WITH AN EVEROLIMUS ELUTING STENT: INSIGHTS FROM THE XIENCE SHORT DAPT PROGRAM.
37. PROGNOSTIC VALUE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PCI.
38. Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7.
39. ADDITIVE EFFECT OF MULTIPLE HIGH BLEEDING RISK CRITERIA IN PATIENTS UNDERGOING PCI.
40. PERFORMANCE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA ACCORDING TO SEX.
41. THE EFFECT OF COMPLEX CORONARY REVASCULARIZATION PROCEDURE IN PATIENTS AT HIGH-BLEEDING RISK.
42. TCT-838 Prognostic Value of High-Sensitivity C-Reactive Protein in Percutaneous Coronary Intervention According to Body Mass Index.
43. TCT-630 The Impact of Diabetes Mellitus in Patients Undergoing Percutaneous Coronary Intervention With a Drug Eluting Stent for Unprotected Left Main Stenosis.
44. TCT-544 Influence of Ischemic and Bleeding Risk Factors on Diabetic Patients Undergoing Percutaneous Coronary Intervention: From the Xience Pooled Registry.
45. TCT-542 Impact of Baseline Anemia and Thrombocytopenia on 1-Year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
46. TCT-541 Validation of the Academic Research Consortium–High Bleeding Risk Criteria for Patients Undergoing Percutaneous Coronary Intervention.
47. TCT-406 Clinical Impact of DAPT Cessation Within 12 Months of Drug-Eluting Stent Implantation in Caucasians and Minorities: Insights From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study.
48. TCT-399 Long-Term Cardiovascular Outcomes According to the Antiplatelet Agent Discontinued After Coronary Stenting: Insights From 4 Xience V Post-Approval Studies.
49. TCT-294 Clinical Outcomes in Women and Minorities According to the Urgency of Percutaneous Coronary Intervention.
50. TCT-156 Patterns of Therapy Cessation in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights From the AVIATOR-2 International Registry.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.